Charles River Laboratories International, Inc. (CRL)
USD 183.16
(-3.26%)
USD 183.16
(-3.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.78 Billion USD | -2.58% |
| 2022 | 2.86 Billion USD | 6.92% |
| 2021 | 2.67 Billion USD | 40.44% |
| 2020 | 1.9 Billion USD | 7.95% |
| 2019 | 1.76 Billion USD | 19.96% |
| 2018 | 1.47 Billion USD | 50.06% |
| 2017 | 981.3 Million USD | -12.18% |
| 2016 | 1.11 Billion USD | 49.97% |
| 2015 | 745.08 Million USD | 20.6% |
| 2014 | 617.83 Million USD | 21.65% |
| 2013 | 507.86 Million USD | -8.79% |
| 2012 | 556.83 Million USD | -14.21% |
| 2011 | 649.04 Million USD | 24.41% |
| 2010 | 521.69 Million USD | 68.15% |
| 2009 | 310.25 Million USD | -6.69% |
| 2008 | 332.5 Million USD | 16.83% |
| 2007 | 284.6 Million USD | -28.25% |
| 2006 | 396.68 Million USD | 118.15% |
| 2005 | 181.84 Million USD | -62.06% |
| 2004 | 479.27 Million USD | 14198.3% |
| 2003 | 3.35 Million USD | -95.21% |
| 2002 | 69.97 Million USD | -28.98% |
| 2001 | 98.52 Million USD | -41.97% |
| 2000 | 169.78 Million USD | -54.24% |
| 1999 | 371.03 Million USD | 1697.29% |
| 1998 | -23.22 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 2.74 Billion USD | -1.64% |
| 2024 Q2 | 2.66 Billion USD | -2.99% |
| 2023 Q2 | 2.87 Billion USD | -2.73% |
| 2023 FY | 2.78 Billion USD | -2.58% |
| 2023 Q3 | 2.74 Billion USD | -4.59% |
| 2023 Q1 | 2.96 Billion USD | 3.39% |
| 2023 Q4 | 2.78 Billion USD | 1.53% |
| 2022 Q3 | 3.15 Billion USD | -1.54% |
| 2022 Q1 | 2.73 Billion USD | 2.28% |
| 2022 FY | 2.86 Billion USD | 6.92% |
| 2022 Q4 | 2.86 Billion USD | -9.36% |
| 2022 Q2 | 3.2 Billion USD | 17.13% |
| 2021 Q2 | 2.74 Billion USD | 41.68% |
| 2021 Q4 | 2.67 Billion USD | -9.47% |
| 2021 FY | 2.67 Billion USD | 40.44% |
| 2021 Q1 | 1.93 Billion USD | 1.67% |
| 2021 Q3 | 2.95 Billion USD | 7.7% |
| 2020 Q4 | 1.9 Billion USD | -1.94% |
| 2020 Q1 | 2.15 Billion USD | 22.16% |
| 2020 Q3 | 1.94 Billion USD | -4.23% |
| 2020 Q2 | 2.03 Billion USD | -5.9% |
| 2020 FY | 1.9 Billion USD | 7.95% |
| 2019 Q3 | 1.88 Billion USD | -5.65% |
| 2019 Q2 | 2 Billion USD | 27.23% |
| 2019 FY | 1.76 Billion USD | 19.96% |
| 2019 Q4 | 1.76 Billion USD | -6.46% |
| 2019 Q1 | 1.57 Billion USD | 6.83% |
| 2018 Q1 | 944.94 Million USD | -3.71% |
| 2018 Q3 | 1.54 Billion USD | -5.5% |
| 2018 Q4 | 1.47 Billion USD | -4.72% |
| 2018 FY | 1.47 Billion USD | 50.06% |
| 2018 Q2 | 1.63 Billion USD | 73.08% |
| 2017 Q2 | 1.02 Billion USD | -3.64% |
| 2017 Q4 | 981.3 Million USD | -7.38% |
| 2017 FY | 981.3 Million USD | -12.18% |
| 2017 Q1 | 1.06 Billion USD | -4.61% |
| 2017 Q3 | 1.05 Billion USD | 3.16% |
| 2016 Q2 | 1.21 Billion USD | 71.81% |
| 2016 FY | 1.11 Billion USD | 49.97% |
| 2016 Q3 | 1.15 Billion USD | -4.71% |
| 2016 Q4 | 1.11 Billion USD | -3.13% |
| 2016 Q1 | 704.48 Million USD | -5.45% |
| 2015 Q1 | 634.49 Million USD | 2.7% |
| 2015 FY | 745.08 Million USD | 20.6% |
| 2015 Q4 | 745.08 Million USD | -4.28% |
| 2015 Q3 | 778.36 Million USD | 25.15% |
| 2015 Q2 | 621.96 Million USD | -1.97% |
| 2014 Q1 | 470.96 Million USD | -7.27% |
| 2014 Q2 | 696.53 Million USD | 47.9% |
| 2014 FY | 617.83 Million USD | 21.65% |
| 2014 Q4 | 617.83 Million USD | -5.81% |
| 2014 Q3 | 655.96 Million USD | -5.82% |
| 2013 FY | 507.86 Million USD | -8.79% |
| 2013 Q3 | 510.02 Million USD | -2.37% |
| 2013 Q1 | 548.46 Million USD | -1.5% |
| 2013 Q2 | 522.41 Million USD | -4.75% |
| 2013 Q4 | 507.86 Million USD | -0.42% |
| 2012 Q2 | 610.15 Million USD | -5.15% |
| 2012 FY | 556.83 Million USD | -14.21% |
| 2012 Q1 | 643.28 Million USD | -0.89% |
| 2012 Q4 | 556.83 Million USD | -4.9% |
| 2012 Q3 | 585.52 Million USD | -4.04% |
| 2011 Q2 | 643.58 Million USD | -7.81% |
| 2011 Q4 | 649.04 Million USD | -1.53% |
| 2011 FY | 649.04 Million USD | 24.41% |
| 2011 Q1 | 698.07 Million USD | 33.81% |
| 2011 Q3 | 659.1 Million USD | 2.41% |
| 2010 Q2 | 217.13 Million USD | -13.85% |
| 2010 Q1 | 252.05 Million USD | -18.76% |
| 2010 FY | 521.69 Million USD | 68.15% |
| 2010 Q4 | 521.69 Million USD | -10.28% |
| 2010 Q3 | 581.45 Million USD | 167.78% |
| 2009 Q1 | 339.29 Million USD | 2.04% |
| 2009 FY | 310.25 Million USD | -6.69% |
| 2009 Q4 | 310.25 Million USD | 1.34% |
| 2009 Q3 | 306.14 Million USD | -16.6% |
| 2009 Q2 | 367.08 Million USD | 8.19% |
| 2008 Q3 | 329.86 Million USD | 26.94% |
| 2008 Q1 | 270.23 Million USD | -5.05% |
| 2008 FY | 332.5 Million USD | 16.83% |
| 2008 Q4 | 332.5 Million USD | 0.8% |
| 2008 Q2 | 259.86 Million USD | -3.84% |
| 2007 Q4 | 284.6 Million USD | -14.88% |
| 2007 Q1 | 416.77 Million USD | 5.07% |
| 2007 FY | 284.6 Million USD | -28.25% |
| 2007 Q3 | 334.33 Million USD | -10.57% |
| 2007 Q2 | 373.86 Million USD | -10.3% |
| 2006 Q1 | 205.59 Million USD | 13.07% |
| 2006 FY | 396.68 Million USD | 118.15% |
| 2006 Q4 | 396.68 Million USD | 14.27% |
| 2006 Q3 | 347.15 Million USD | -16.44% |
| 2006 Q2 | 415.46 Million USD | 102.08% |
| 2005 FY | 181.84 Million USD | -62.06% |
| 2005 Q4 | 181.84 Million USD | -13.65% |
| 2005 Q3 | 210.57 Million USD | -12.26% |
| 2005 Q2 | 239.99 Million USD | -47.09% |
| 2005 Q1 | 453.58 Million USD | -5.36% |
| 2004 FY | 479.27 Million USD | 14198.3% |
| 2004 Q4 | 479.27 Million USD | 752.57% |
| 2004 Q3 | -73.44 Million USD | -95.75% |
| 2004 Q2 | -37.52 Million USD | -966.82% |
| 2004 Q1 | -3.51 Million USD | -204.92% |
| 2003 Q3 | 25.44 Million USD | -44.11% |
| 2003 Q4 | 3.35 Million USD | -86.83% |
| 2003 FY | 3.35 Million USD | -95.21% |
| 2003 Q2 | 45.52 Million USD | -39.96% |
| 2003 Q1 | 75.83 Million USD | 8.37% |
| 2002 Q1 | 127.25 Million USD | 29.16% |
| 2002 FY | 69.97 Million USD | -28.98% |
| 2002 Q4 | 69.97 Million USD | -8.17% |
| 2002 Q3 | 76.19 Million USD | -26.97% |
| 2002 Q2 | 104.33 Million USD | -18.01% |
| 2001 Q1 | 176.09 Million USD | 3.72% |
| 2001 Q2 | 174.14 Million USD | -1.11% |
| 2001 FY | 98.52 Million USD | -41.97% |
| 2001 Q3 | 116.34 Million USD | -33.19% |
| 2001 Q4 | 98.52 Million USD | -15.31% |
| 2000 Q3 | 175.08 Million USD | -54.05% |
| 2000 Q1 | 379.68 Million USD | 0.0% |
| 2000 Q2 | 381.02 Million USD | 0.35% |
| 2000 Q4 | 169.78 Million USD | -3.03% |
| 2000 FY | 169.78 Million USD | -54.24% |
| 1999 FY | 371.03 Million USD | 1697.29% |
| 1998 FY | -23.22 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.14 Billion USD | -143.634% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 40.431% |
| Danaher Corporation | 13.67 Billion USD | 79.596% |
| Enzo Biochem, Inc. | -52.1 Million USD | 5453.721% |
| IQVIA Holdings Inc. | 12.85 Billion USD | 78.299% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 48.506% |
| Mettler-Toledo International Inc. | 2.01 Billion USD | -38.715% |
| Qiagen N.V. | 943.04 Million USD | -195.81% |
| Revvity, Inc. | 3.11 Billion USD | 10.533% |
| Thermo Fisher Scientific Inc. | 26.84 Billion USD | 89.607% |
| Waters Corporation | 1.96 Billion USD | -42.295% |